Apotex is a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) for patients around the world. We are the 7th largest generic pharmaceutical company globally with more than 12,000 employees and estimated sales of approximately $3 billion. Our fully integrated operation is comprised of four lines of business: Global Generics; Apobiologix; Global Active Pharmaceutical Ingredients (API); and ApoPharma (Innovative Products). With our worldwide manufacturing sites, Apotex can produce up to 24 billion dosages per year. We produce 300 medicines in 4,000 dosages and formats that are exported to 115 countries. Apotex will spend $2 billion over the next 10 years on research and development.
Performs global Pharmacovigilance processes of the unit: Medical assessment and quality review of Individual case safety reports (ICSR), including submission to regulatory authorities as needed; Compliance monitoring and tracking; Reconciliation; Literature review, and occasional case processing as needed. Contributes to drafting and review of aggregate reports and Risk Management plans on products developed and manufactured by Apotex, in compliance with global drug safety regulations and ICH Guidelines. Interacts with health professionals and consumers and affiliate offices during investigation of all case reports. When required, participates in global new product development (NPD) project teams and supports Product Life Cycle Management (PLCM) activities relating to Risk Management programs as required.
- Perform medical review of ICSRs and generate follow-up questions as appropriate.
- Conduct literature assessment for ADRs and medical review of articles.
- Conduct causality assessments for safety cases reports.
- MedDRA coding assessment
- Perform expectedness and listedness assessment and ICSR reportability.
- Conduct quality review of ICSRs.
- Contribute to submissions of ICSRs when required.
- Assist in the preparation, review and evaluation of signals, aggregate reports and risk management plans
- Contribute in generating responses to regulatory authority requests on product safety related issues for marketed products or product in development.
- Respond to queries from clients (including internal and external to Apotex Inc.) in a timely manner.
- Perform monthly or quarterly reconciliations of reports as required.
- Assist in the maintenance of unit SODs, Safety Data Exchange agreements with business partners and internal work instructions.
- Maintain departmental document management, including scanning and filing of source documents.
- Contribute to maintenance and compliance oversight of PV processes, external service providers and business partners. May contribute to preparation and training of internal and external customers on adverse events reporting
- Escalates to Project Leader, calls and requests for Health Care Professional consultation involving safety issues.
- Contribute to process improvement initiatives in consultation with management.
- Works as a member of a team to achieve all outcomes.
- Performs all work in support of our Corporate Values of Collaboration, Courage, Perseverance, Passion; Demonstrates strong and visible support of our values.
- Performs all work in accordance with all established regulatory and compliance and safety requirements.
- All other duties as assigned.
At Apotex, we are committed to fostering an inclusive, accessible work environment, where all employees feel valued, respected and supported.
Apotex offers accommodation for applicants with disabilities as part of its recruitment process. If you are contacted to arrange for an interview or testing, please advise us if you require an accommodation.
Apotex Inc. was founded in 1974, and is the largest Canadian-owned pharmaceutical company. From its 2 employees, 5,000 square foot beginning, the company has grown to employ over 6,500 people in research, development, manufacturing and distribution facilities world-wide. The Canadian operations of the Apotex Group of Companies with 5,800 employees now occupy over 3 million square feet in Montreal, Richmond Hill, Toronto, Etobicoke, Mississauga, Brantford, Windsor, Winnipeg, London, Calgary and Vancouver. Apotex produces more than 300 generic pharmaceuticals in approximately 4,000 dosages and formats which, in Canada, are used to fill over 89 million prescriptions a year – the largest amount of any pharmaceutical company in this country.
Today, Apotex is a necessary and trusted member of Canada’s healthcare community. The company’s pharmaceuticals can be found in virtually every pharmacy and healthcare facility in Canada and are exported to over 115 countries around the globe. Export markets represent an ever growing portion of the total sales. Apotex has also established a presence through subsidiaries, joint ventures or licensing agreements in Australia, Belgium, Czech Republic, Mexico, Netherlands, New Zealand, Poland, Turkey, and the in, to name just a few. Healthcare professionals around the world rely on Apotex for quality and value.
Although the company’s own business is developing and manufacturing generic pharmaceuticals, the success of Apotex has enabled it to diversify into a number of other health-related areas. The Apotex Pharmaceutical Group of Companies also researches, develops, manufactures and distributes fine chemicals, non-prescription and private label medicines, and disposable plastics for medical use.
The worldwide sales of the Apotex Group of companies exceed $1 billion (Canadian $) per year.